MASIMO CORP
masimo.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q1 FY2026 10-Q, filed May 5, 2026. Its latest SEC filing is a SCHEDULE 13G/A from Aug 14, 2026.
10-Q for Q1 FY2026, filed May 5, 2026
The sections below describe the company as of the FY2025 annual report.
What Did They Do?
Sells patient-monitoring systems and sensors, hospital automation and connectivity solutions, and remote-monitoring devices to hospitals, emergency and home-care providers, and other care facilities.
10-K for FY2025, filed Feb 27, 2026Our healthcare business develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation®…View ↗
How Did They Make Money?
Hospitals can receive monitoring equipment at no upfront charge in exchange for buying sensors under multi-year agreements; Masimo also sells monitoring products and circuit boards to hospitals, emergency-response groups, distributors, and OEMs, while operating-lease revenue is spread over the lease term.
10-K for FY2025, filed Feb 27, 2026The Company derives the majority of its revenue from four primary sources: (i) direct sales under deferred equipment agreements with…View ↗
Sales under deferred equipment agreements are generally structured such that the Company agrees to provide certain monitoring-related…View ↗
For contracts that contain variable lease payments that are not dependent on an index or rate, the Company classifies as operating leases…View ↗
$1.5B
-
10-K for FY2025, filed Feb 27, 2026
$1.5B ↗
Who Were Their Customers?
Hospitals and other care providers buy directly from Masimo or through distributors; OEM partners buy circuit boards for use in their multiparameter monitors.
10-K for FY2025, filed Feb 27, 2026
Did Revenues Turn Into Profits?
Not on paper. It lost $151.5M in FY2025, but brought in more cash than it spent: $198.4M of free cash flow.
How Were They Changing?
- Net income
-
Sources
10-Q for Q1 FY2026, filed May 6, 2026
$57.1MView ↗
- ▲ Now profitable
- vs −$170.7M in Q1 FY2025
-
Jun 10, 2026
Danaher completed its acquisition of Masimo
Each share converted into the right to receive $180.00 in cash, and the stock ceased trading on Nasdaq.
Sources
8-K, filed Jun 10, 2026
Pursuant to the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each share of common stock, par value $0.001…View ↗
Grew. Revenue grew 23% in 4 years, from $1.2B in FY2021 to $1.5B in FY2025, about 5% a year.
Consumer audio exit
The older report described consumer audio sales and licensing; the latest report says the non-healthcare consumer business was sold.
10-K for FY2022, filed Mar 1, 2023 10-K for FY2025, filed Feb 27, 2026Our non-healthcare consumer audio business develops, manufactures, markets, sells and licenses premium and luxury audio, and related…View ↗
As of December 28, 2024, the non-healthcare consumer business remained part of the Company’s continuing operations, but was being evaluated…View ↗
Loading...
